These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An attenuated multiple genetic mutant of Mycoplasma pneumoniae imparts good immuno-protection against M. pneumoniae pneumonia in BALB/c mice. Jiang Z; Zhou R; Leung PHM; Deng Z; Li S Microb Pathog; 2022 Apr; 165():105463. PubMed ID: 35240287 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of Mycoplasma pneumoniae: An update. Chaudhry R; Ghosh A; Chandolia A Indian J Med Microbiol; 2016; 34(1):7-16. PubMed ID: 26776112 [TBL] [Abstract][Full Text] [Related]
4. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534 [TBL] [Abstract][Full Text] [Related]
5. Insight into the Pathogenic Mechanism of Mycoplasma pneumoniae. Hu J; Ye Y; Chen X; Xiong L; Xie W; Liu P Curr Microbiol; 2022 Dec; 80(1):14. PubMed ID: 36459213 [TBL] [Abstract][Full Text] [Related]
6. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Cao B; Qu JX; Yin YD; Eldere JV Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811 [TBL] [Abstract][Full Text] [Related]
7. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439 [TBL] [Abstract][Full Text] [Related]
8. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Gillies MB; Chang AB Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079 [TBL] [Abstract][Full Text] [Related]
9. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Gardiner SJ; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754 [TBL] [Abstract][Full Text] [Related]
14. Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan. Hausner M; Schamberger A; Naumann W; Jacobs E; Dumke R Microb Pathog; 2013 Nov; 64():23-32. PubMed ID: 23948467 [TBL] [Abstract][Full Text] [Related]
15. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Gavranich JB; Chang AB Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954 [TBL] [Abstract][Full Text] [Related]